(Kayexalate)
1,115 results
  • Selective protein separation enabled by asymmetric three-component coacervates. [Journal Article]
    Soft Matter. 2026 Oct 07; 22(38):6534-6542.Apuzzo E, Bianchi DS, … Agazzi MLSM
  • Selective protein separation via complex coacervation offers a sustainable alternative to conventional purification methods. Here, we investigate asymmetric coacervates formed by a polyelectrolyte and an oppositely charged multivalent ion as a platform for separating proteins from mixed solutions based on their isoelectric point (pI). Model systems include bovine serum albumin (BSA, pI ∼ 5.5) and…
  • Evolving Pharmacological Management of Hyperkalemia: Insights for Nephrology Clinicians. [Journal Article]
    Nephrol Nurs J. 2026 Jul-Aug; 53(4):373-379.Haras MSNN
  • Hyperkalemia is a life-threatening complication affecting up to 30% of patients with chronic kidney disease or end stage kidney disease, requiring urgent intervention to mitigate cardiac arrhythmias. Acute management focuses on three main goals: stabilizing the myocardial membrane with calcium gluconate, shifting potassium into cells using insulin and glucose, and removing excess potassium from t…
  • Additive Manufacturing of PEDOT:PSS Electrodes on Collagen Substrates for Soft and Bioactive Electronics. [Journal Article]
    ACS Appl Mater Interfaces. 2026 Sep 02; 18(34):46065-46078.Liu T, Park J, … Rutz ALAA
  • Traditional bioelectronic devices are limited by poor biointerfacing due to their substantial mismatch in mechanical and biochemical properties. In tissue engineering, soft and bioactive materials support biointegration by harnessing or mimicking the natural extracellular matrix (ECM). Building bioelectronic devices from ECM should improve their biointegration, yet there are limited methods to fa…
  • Malignancy-mimicking Kayexalate-associated extraintestinal mass and literature review. [Case Reports]
    Clin J Gastroenterol. 2026 Aug; 19(4):744-750.Magri J, Hajar C, … Lewin DCJ
  • The gastrointestinal side effects of Kayexalate administration are well-established, and despite its discontinued use in the United States, it is still important to consider in the clinical and pathologic differential, given the vast time range between administration and clinical presentation. One less common, though significant, complication of Kayexalate use is the formation of a malignancy-mim…